D'Haens G - Search Results

1

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.

Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.

2

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease.

D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. D'Haens G, et al. Gastroenterology. 1997 May;112(5):1475-81. doi: 10.1016/s0016-5085(97)70027-1. Gastroenterology. 1997. PMID: 9136824

3

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ. Baert FJ, et al. Gastroenterology. 1999 Jan;116(1):22-8. doi: 10.1016/s0016-5085(99)70224-6. Gastroenterology. 1999. PMID: 9869598 Clinical Trial.

4

Methotrexate in refractory Crohn's disease.

Vandeputte L, D'Haens G, Baert F, Rutgeerts P. Vandeputte L, et al. Inflamm Bowel Dis. 1999 Feb;5(1):11-5. doi: 10.1097/00054725-199902000-00002. Inflamm Bowel Dis. 1999. PMID: 10028444

5

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, Mayer L, Van Hogezand RA, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJ. Rutgeerts P, et al. Gastroenterology. 1999 Oct;117(4):761-9. doi: 10.1016/s0016-5085(99)70332-x. Gastroenterology. 1999. PMID: 10500056 Clinical Trial.

6

Crohn's disease and intestinal endometriosis: an intriguing co-existence.

Craninx M, D'Haens G, Cokelaere K, Baert F, Penninckx F, D'Hoore A, Ectors N, Rutgeerts P, Geboes K. Craninx M, et al. Eur J Gastroenterol Hepatol. 2000 Feb;12(2):217-21. doi: 10.1097/00042737-200012020-00014. Eur J Gastroenterol Hepatol. 2000. PMID: 10741938

7

Mycophenolate mofetil in Crohn's disease.

Rampton DS, Neurath MF, Almer S, D'Haens G, Petritsch W, Stange EF. Rampton DS, et al. Lancet. 2000 Jul 8;356(9224):163-4. doi: 10.1016/s0140-6736(05)73176-7. Lancet. 2000. PMID: 10963270 Clinical Trial. No abstract available.

8

Prevention of postoperative recurrence in Crohn's disease.

D'Haens G. D'Haens G. Curr Gastroenterol Rep. 1999 Dec;1(6):476-81. doi: 10.1007/s11894-999-0006-6. Curr Gastroenterol Rep. 1999. PMID: 10980989 Review.

9

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.

D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans L, Peeters M, Vermeire S, Penninckx F, Nevens F, Hiele M, Rutgeerts P. D'Haens G, et al. Gastroenterology. 2001 May;120(6):1323-9. doi: 10.1053/gast.2001.23983. Gastroenterology. 2001. PMID: 11313301 Clinical Trial.

10

Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.

D'Haens G, Swijsen C, Noman M, Lemmens L, Ceuppens J, Agbahiwe H, Geboes K, Rutgeerts P. D'Haens G, et al. Am J Gastroenterol. 2001 Sep;96(9):2564-8. doi: 10.1111/j.1572-0241.2001.04705.x. Am J Gastroenterol. 2001. PMID: 11569676 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

599 results

Search Page